Lixia Li

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Guangdong Medical College, Guangdong Pharmaceutical University, Dongguan People’s Hospital · ORCID：0000-0002-2772-264X

发表论文 449 篇 · 总被引 11844 次 · h-index 56

代表论文

• Delivery of penetration-enhancing antioxidant polyphenol nanoparticles with Codonopsis pilosula polysaccharide microneedles for synergistic treatment of psoriasis (2025 · Carbohydrate Polymers · 被引 21)
• Pore Structure Characteristics of Carbonate Rocks and Their Influence on Permeability (2025 · ACS Omega · 被引 9)
• Rhein restores the sensitivity of mcr-1 carrying multidrug-resistant Escherichia coli to colistin (2025 · Frontiers in Microbiology · 被引 6)
• Optimizing meropenem therapy in critical infections: a review of pharmacokinetics/pharmacodynamics research and clinical practice (2025 · Expert Review of Clinical Pharmacology · 被引 6)
• Quaternized chitosan-coated PLGA nanoparticles co-deliver resveratrol and all-trans retinoic acid to enhance humoral immunity, cellular immunity and gastrointestinal mucosal immunity (2025 · Colloids and Surfaces B Biointerfaces · 被引 5)
• Identification of the GST Gene Family and Functional Analysis of RcGSTF2 Related to Anthocyanin in Rosa chinensis ‘Old Blush’ (2025 · Plants · 被引 5)